We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
- Authors
Freedman, A S; Neuberg, D; Gribben, J G; Mauch, P; Soiffer, R J; Fisher, D C; Anderson, K C; Andersen, N; Schlossman, R; Kroon, M; Ritz, J; Aster, J; Nadler, L M
- Abstract
The role for high-dose therapy and autologous stem-cell transplantation in mantle-cell lymphoma (MCL) is unknown. We retrospectively analyzed patients with chemosensitive disease who underwent high-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation (ABMT) for MCL in first remission, as well as following relapse from conventional therapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Vol 16, Issue 1, p13
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1998.16.1.13